Cite

    Shiomi, M. et al. (n.d.). Pharmacokinetic and bioequivalence evaluation of single‐tablet and separate‐tablet regimens for once‐daily cobicistat‐boosted elvitegravir in healthy Japanese male subjects: A randomized, two‐way crossover study. Clinical pharmacology in drug development. 4 (3), pp. 218-225. [Online].